Cereblon Control of Zebrafish Brain Size by Regulation of Neural Stem Cell Proliferation
Author(s) -
Hideki Ando,
Tomomi Sato,
Takumi Ito,
Junichi Yamamoto,
Satoshi Sakamoto,
Nobuhiro Nitta,
Tomoko AsatsumaOkumura,
Nobuyuki Shimizu,
Ryota Mizushima,
Ichio Aoki,
Takeshi Imai,
Yuki Yamaguchi,
Arnold Berk,
Hiroshi Handa
Publication year - 2019
Publication title -
iscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.805
H-Index - 27
ISSN - 2589-0042
DOI - 10.1016/j.isci.2019.04.007
Subject(s) - cereblon , zebrafish , neural stem cell , gene knockdown , biology , ubiquitin ligase , microbiology and biotechnology , stem cell , cell growth , neural development , gene , neuroscience , ubiquitin , genetics
Thalidomide is a teratogen that causes multiple malformations in the developing baby through its interaction with cereblon (CRBN), a substrate receptor subunit of the CRL4 E3 ubiquitin ligase complex. CRBN was originally reported as a gene associated with autosomal recessive non-syndromic mild mental retardation. However, the function of CRBN during brain development remains largely unknown. Here we demonstrate that CRBN promotes brain development by facilitating the proliferation of neural stem cells (NSCs). Knockdown of CRBN in zebrafish embryos impaired brain development and led to small brains, as did treatment with thalidomide. By contrast, overexpression of CRBN resulted in enlarged brains, leading to the expansion of NSC regions and increased cell proliferation in the early brain field and an expanded expression of brain region-specific genes and neural and glial marker genes. These results demonstrate that CRBN functions in the determination of brain size by regulating the proliferation of NSCs during development.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom